Hospira Inc., A Pfizer Company recalls Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, H
Recalled December 28, 2016 · FDA recall D-0218-2017 · Hospira Inc., A Pfizer
Hazard
Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial. · FDA Class I
Units
143,250 vials
Sold at
Nationwide
Description
Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.
Product
Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1159-02
Manufacturer(s)
Hospira Inc., A Pfizer Company
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →